Breaking through a significant resistance level at $12 could open the path toward a surge to $50, boosting bullish momentum. Projections suggest potential targets of $100 and even $200 based on Elliott Wave structures and accumulation patterns. Intraday stability near $12.67 suggests easing downside pressure, with $13.20 as immediate resistance. Injective traded under pressure but remains focused on its major resistance near $17. A breakout above this level could drive momentum towards $50. The $17 area holds both technical and psychological significance, representing a crucial barrier in the short term. If buying strength sustains above $17, momentum could accelerate rapidly. Breakouts from such levels often trigger extended rallies. Injective remains positioned for potential upside if this threshold is crossed decisively. Background analysis shows past cycles where similar setups resulted in strong follow-through moves. Thus, the $17 breakout remains a key trigger for the next rally phase. Long-term price projections suggest ambitious targets of $100 and even $200. These projections stem from Elliott Wave structures, accumulation phases, and historical price action, indicating potential for exponential growth under favorable market conditions. The focus is now on Injective breaking above the major $17 resistance to propel the next rally phase. Will $INJ be a rocket this time? Everyone is eyeing the breakout.